ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

BIO supports American Research and Competitiveness Act.

Print | 
Email |  Comment   Share  
May 19, 2014 - BIO applauds U.S. House passage of the American Research and Competitiveness Act (H.R. 4438), which would establish a permanent research tax credit. According to BIO President and CEO Jim Greenwood, the R&D tax credit is a vitally important incentive that spurs private-sector funding of the search for new cures and treatments for patients in need. This research not only produces new groundbreaking medical discoveries, but also supports millions of well-paying American jobs.

BIO Applauds House Passage of the American Research and Competitiveness Act


Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
USA



Press release date: May 9, 2014

Bill would strengthen, make permanent critical R&D tax credit

WASHINGTON--The Biotechnology Industry Organization applauds the passage today by the US House of Representatives of the American Research and Competitiveness Act (H.R. 4438), which would establish a permanent research tax credit.

“The R&D tax credit is a vitally important incentive that spurs private-sector funding of the search for new cures and treatments for patients in need. This research not only produces new groundbreaking medical discoveries, but also supports millions of well-paying American jobs.”

The following statement may be attributed to BIO President and CEO Jim Greenwood:

“BIO strongly supports the American Research & Competitiveness Act (H.R. 4438), which would strengthen and make permanent the R&D tax credit, and we thank Rep. Kevin Brady (R-TX) for his leadership.”

“The R&D tax credit is a vitally important incentive that spurs private-sector funding of the search for new cures and treatments for patients in need. This research not only produces new groundbreaking medical discoveries, but also supports millions of well-paying American jobs.”

“The current environment of uncertainty about whether the credit will be extended makes tax planning extremely difficult for companies preparing their development programs. Making the credit permanent would recognize its vital role in supporting America’s innovation economy while providing certainty for businesses working toward the next generation of medical breakthroughs.”

“The R&D tax credit is an important tool incentivizing investment at companies with established revenue streams, and we welcome this bill to strengthen and make it permanent.”

“However, it is important to recognize the tremendous investments in research made by smaller, pre-revenue companies which do not yet have a tax liability. Such companies are unable to take advantage of the R&D tax credit as currently structured. BIO believes that this critical research should be incentivized in the tax code regardless of the size of the company involved, and we hope to work with Congress to that end.”

For more information on policies affecting emerging biotech companies, please visit http://www.bio.org/ecs.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA

BIO International Convention
June 23-26, 2014
San Diego, CA

BIO Latin America Conference
September 9-11, 2014
Rio de Janeiro, Brazil

Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD

Contacts
Biotechnology Industry Organization
Daniel Seaton, 202-470-5207
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech

Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Services
| Featured Manufacturing Jobs
 Other News from this company:
The 13th Annual BIO Investor Forum to Host Over 100 Presenting Companies
Dr. Richard Raymond to Be Keynote Speaker for 2014 BIO Livestock Biotech Summit
BIO Launches Survey on FDA/Sponsor Interactions During Drug Development
13th Annual BIO Investor Forum to Highlight IPO Success Since Passage of JOBS Act
BIO Extends Deadline on Call for Papers for 2014 Pacific Rim Summit on Industrial Biotechnology and Bioenergy
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Trade Associations


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address